| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.00B | -95.4% |
| Gross profit | ¥-0.00B | — |
| Operating income | ¥-0.02B | — |
| Net income | ¥-0.02B | — |
| Gross margin | -25.7% | Net margin -1070.0% |
| Revenue Q/Q | -49.5% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.00B | 125.7% |
| SG&A | ¥0.01B | 580.0% |
| Tax & other | ¥0.00B | 2.1% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
红相股份 ・ 立中集团 ・ 强力新材 ・ *ST益通 ・ 富临精工 ・ 金石亚药 ・ 中泰股份 ・ 广生堂 ・ 清水源 ・ 鹏辉能源 ・ 美康生物 ・ 运达科技
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies